Fifty 1 Labs, Inc. (FITY)
OTCMKTS · Delayed Price · Currency is USD
0.0015
-0.0002 (-11.76%)
Oct 17, 2025, 3:57 PM EDT
Fifty 1 Labs Revenue
Fifty 1 Labs had revenue of $998.05 thousand in the quarter ending March 31, 2011, a decrease of -20.87%. This brings the company's revenue in the last twelve months to $4.08 million, down -29.40% year-over-year. In the fiscal year ending June 30, 2010, Fifty 1 Labs had annual revenue of $5.11 million, down -5.64%.
Revenue (ttm)
4.08M
Revenue Growth
-29.40%
P/S Ratio
0.22
Revenue / Employee
163.06K
Employees
25
Market Cap
895.62K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2010 | 5.11M | -305.13K | -5.64% |
| Jun 30, 2009 | 5.41M | 905.69K | 20.10% |
| Jun 30, 2008 | 4.51M | -2.44M | -35.11% |
| Jun 30, 2007 | 6.94M | -4.74M | -40.57% |
| Jun 30, 2006 | 11.68M | 9.59M | 458.26% |
| Jun 30, 2005 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Federal National Mortgage Association | 28.89B |
| Federal Home Loan Mortgage | 22.97B |
| First National of Nebraska | 1.89B |
| Central Bancompany | 914.42M |
| W.T.B. Financial | 369.33M |
| Farmers & Merchants Bank of Long Beach | 263.72M |
| Farmers & Merchants Bancorp | 230.93M |
| First National Bank Alaska | 204.38M |
Fifty 1 Labs News
- 9 days ago - Fifty 1 Labs Inc. Appoints Dr. Joel Gagnier as Chief Science Officer - GlobeNewsWire
- 18 days ago - Fifty 1 Labs Inc. Signs Letter of Intent to Acquire BioSpark AI Technologies Inc. - GlobeNewsWire
- 25 days ago - Fifty 1 Labs, Inc. Engages PCAOB Auditing Firm to Prepare for Uplist to OTCQB - GlobeNewsWire
- 6 weeks ago - Fifty1 Labs, Inc. Leadership Publishes Landmark Framework to Unlock Global Oncology Data Through AI-Driven Real-World Evidence - GlobeNewsWire
- 7 weeks ago - Fifty1 Labs Partners with LUNR Aerospace to Pioneer AI-Driven Drug Repurposing for Space Medicine, Strategic Collaboration Aims to Harness AI and Orbital Access to Revolutionize Astronaut Health Solutions in a $2 Billion Market by 2032 - GlobeNewsWire
- 2 months ago - Fifty 1 Labs, Inc. and The Gates Foundation Lead Largest-Ever Sickle Cell Disease Study, Unlocking Pathways for Gene-Based and Repurposed Therapies - GlobeNewsWire
- 2 months ago - Fifty1 Labs, Inc. and BioSpark AI Unlock 2,000+ Real-World Treatment Pathways to Accelerate Functional Medicine Innovation - GlobeNewsWire
- 3 months ago - Fifty 1 Labs, Inc. (FITY) Sparks AI Breakthrough in Drug Repurposing: Subsidiary Fifty1 AI Labs Announces Strategic Partnership with Intent to Acquire BioSpark AI Technologies - GlobeNewsWire